Skip to content
My WebMD Sign In, Sign Up

Thomas L Schwartz, MD

Joined: 02/10/2010
Expert Profile:
Thomas L. Schwartz, MD, received his medical degree from and completed his residency in adult psychiatry at the State University of New York (SUNY) Upstate Medical University in Syracuse, where he also served as chief resident.

Schwartz is associate professor of psychiatry, director of adult outpatient services, and assistant director for psychiatric residency training at SUNY Upstate Medical University, where he also directs the Depression & Anxiety Disorders Research Program. Active on many committees at SUNY, he also provides direct resident supervision, lectures in several courses, and directs and organizes continuing medical education events for the psychiatry department. Schwartz also maintains a private practice and consults for the Indian Health Service, the Neuroscience Education Institute, pharmaceutical companies, and associated industries.

He is a member of American Psychiatric Association, American Medical Association, and Medical Society of the State of New York. Schwartz's contributions to the field have been recognized with the Marc H. Hollander, MD, Psychiatry Award, Teacher of the Year and Mentor of the Year awards from SUNY Upstate Medical University; and the Nancy Roeske and Irma Bland teaching awards from the American Psychiatric Association.

Schwartz has served as principle investigator on many clinical trials; his clinical and research interests include treatment-resistant depression and anxiety, psychosomatic illness, adult psychopharmacology, and antidepressant augmentation for efficacy and tolerability.

He is the author of Depression: Treatment Strategies and Management, 2nd Ed. and enjoys speaking in support of his research; he has published numerous articles in peer-reviewed medical journals. Schwartz also has served as peer reviewer for several U.S. and international journals.


Dr Schwartz has served as a consultant and/or speaker for AstraZeneca and Cephalon

Latest Activity

Filter by:
Reply: Dr. Schwartz: Paxil CR update after 15 days!!
yes- paxil side effects occur. usually we wait them out and they go away. or...More
Reply: Provigil or Nuvigil
Hi- yes, I authored one there are small studies, most peer reviewed BUT...More
Reply: Recently Diagnosed With a Question
I agree. Xanax is not approved for depression, just certain anxieties....More
you know all about ECT. it is very good, but the treatments make you tired,...More
Reply: stammering while talking to people
Hi, you may have performance or social anxiety. See if webMD has an anxiety...More
Reply: Multiple Antidepressants?
hello- some antidepressants can be mixed easy for better effectiveness. that...More
Reply: Generic antidepressants
Hi- generally speaking, generics can be anywhere from about 15% weaker to 15%...More
Reply: Gastric Bypass and Anti-Depressant
hmm. I am not sure why it is the only antidepressant she can take... celexa...More
Reply: Dr. Schwartz: Started Paxil CR (3 days ago)
Hi- in general, the nausea should go away within several days. Agitation side...More
Reply: saphris and drug test
I am not sure. Assuming you did not take xanax, klonopin,...More